23 January 2017
News and Views
Links and Services
A study in the latest issue of the Alimentary Pharmacology & Therapeutics prospectively examines the prevalence of Epstein–Barr Virus in a population of patients with inflammatory bowel disease.
The Epstein–Barr Virus (EBV) is truly prolific, with a prevalence of more than 90% in the adult h
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors